Save your place

Sign in to WhoBought

Please try again later.

Edgewise Therapeutics, Inc. (EWTX) institutional ownership

Latest close $38.43 Jul 31, 2026
Market cap$1.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
191
reported EWTX position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
101 buyers · 90 sellers

Edgewise Therapeutics, Inc. (EWTX) price and institutional activity

Dates

Q1 2026

$0 bought by 101 investors
Janus Henderson Group PLCParadigm Biocapital Advisors LP +99 more
$0 sold by 90 investors
Braidwell LPUBS Group AG +88 more
Bought Sold Totals per quarter; hover a bar for the names.

Edgewise Therapeutics, Inc. (EWTX) institutional activity · 191

Investor Type Est. change Change Δ Own Date
Braidwell LP · Reduced
Change −2.9M Date Q1 2026
Braidwell LP Reduced· Q1 2026 −2.9M Q1 2026
Janus Henderson Group PLC · Added
Change +1.3M Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +1.3M Q1 2026
Paradigm Biocapital Advisors LP · Added
Change +824K Date Q1 2026
Paradigm Biocapital Advisors LP Added· Q1 2026 +824K Q1 2026
UBS Group AG · Reduced
Change −806K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −806K Q1 2026
Deerfield Management Company, L.P. · Exited
Change −766K Δ Own −100.0% Date Q1 2026
Deerfield Management Company, L.P. Exited· Q1 2026 −766K −100.0% Q1 2026
Norges · Exited
Change −751K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −751K −100.0% Q1 2026
Alliancebernstein L.P. · Added
Change +686K Date Q1 2026
Alliancebernstein L.P. Added· Q1 2026 +686K Q1 2026
Morgan Stanley · Reduced
Change −665K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −665K Q1 2026
First Light Asset Management, LLC · Reduced
Change −572K Date Q1 2026
First Light Asset Management, LLC Reduced· Q1 2026 −572K Q1 2026
Soleus Capital Management, L.P. · Added
Change +540K Date Q1 2026
Soleus Capital Management, L.P. Added· Q1 2026 +540K Q1 2026
Qube Research & Technologies Ltd · Added
Change +530K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +530K Q1 2026
Eventide Asset Management, LLC · Reduced
Change −418K Date Q1 2026
Eventide Asset Management, LLC Reduced· Q1 2026 −418K Q1 2026
Eversept Partners, LP · Exited
Change −337K Δ Own −100.0% Date Q1 2026
Eversept Partners, LP Exited· Q1 2026 −337K −100.0% Q1 2026
FMR LLC · Added
Change +324K Δ Own +46.8% Date Q1 2026
FMR LLC Added· Q1 2026 +324K +46.8% Q1 2026
Citadel Advisors LLC Added· Q1 2026 +306K +248.5% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 191

Famous investor activity in Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics, Inc. (EWTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Russell Alan J. · Director 2 operations −$7.9M
Price $39.41 Qty −200K Owned 25K ΔOwn −89.1% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Russell Alan J. Director 2 operations $39.41 −200K −$7.9M 25K −89.1% Jul 1, 2026 Jul 2, 2026
Russell Alan J. · Director 4 operations 0
Price $0.18–$0.45 Owned 1.1M Trade date Jul 1, 2026 Filed date Jul 2, 2026
Russell Alan J. Director 4 operations $0.18–$0.45 0 1.1M Jul 1, 2026 Jul 2, 2026
Fox Jonathan C. · Director Grant (A) 319
Owned 25K ΔOwn +1.3% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Fox Jonathan C. Director Grant (A) 319 25K +1.3% Jul 1, 2026 Jul 1, 2026
Root Jonathan D. · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jul 17, 2026
Root Jonathan D. Director Grant (A) 16K 16K Jun 5, 2026 Jul 17, 2026
Brege Laura · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jun 17, 2026
Brege Laura Director Grant (A) 16K 16K Jun 5, 2026 Jun 17, 2026
Thompson Peter A. · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jun 17, 2026
Thompson Peter A. Director Grant (A) 16K 16K Jun 5, 2026 Jun 17, 2026
Morris Arlene · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jun 17, 2026
Morris Arlene Director Grant (A) 16K 16K Jun 5, 2026 Jun 17, 2026
Edris Badreddin · Director 2 operations 14K
Owned 8K Trade date Jun 5, 2026 Filed date Jun 16, 2026
Edris Badreddin Director 2 operations 14K 8K Jun 5, 2026 Jun 16, 2026
Martin Christopher Nathan · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jun 16, 2026
Martin Christopher Nathan Director Grant (A) 16K 16K Jun 5, 2026 Jun 16, 2026
Fox Jonathan C. · Director Grant (A) 16K
Owned 16K Trade date Jun 5, 2026 Filed date Jun 16, 2026
Fox Jonathan C. Director Grant (A) 16K 16K Jun 5, 2026 Jun 16, 2026
Donovan Joanne M. · Officer Sell −$1.9M
Price $38.57 Qty −50K Owned 4K Trade date May 5, 2026 Filed date May 5, 2026
Donovan Joanne M. Officer Sell $38.57 −50K −$1.9M 4K May 5, 2026 May 5, 2026
Donovan Joanne M. · Officer 2 operations 0
Price $7.08 Owned 75K Trade date May 5, 2026 Filed date May 5, 2026
Donovan Joanne M. Officer 2 operations $7.08 0 75K May 5, 2026 May 5, 2026
Donovan Joanne M. · Officer Sell −$164K
Price $31.29 Qty −5K Owned 4K Trade date May 4, 2026 Filed date May 5, 2026
Donovan Joanne M. Officer Sell $31.29 −5K −$164K 4K May 4, 2026 May 5, 2026
Fox Jonathan C. · Director Grant (A) 339
Owned 25K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Fox Jonathan C. Director Grant (A) 339 25K Apr 1, 2026 Apr 3, 2026
Donovan Joanne M. · Officer Sell −$926K
Price $32.31 Qty −29K Owned 10K Trade date Apr 1, 2026 Filed date Apr 2, 2026
Donovan Joanne M. Officer Sell $32.31 −29K −$926K 10K Apr 1, 2026 Apr 2, 2026
15 of 49
15 of 49 Sign in to continue to older insider transactions.

Edgewise Therapeutics, Inc. (EWTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Orbimed Advisors LLC 14.8M
% of shares outstanding 15.6% Filing date Nov 12, 2024
Orbimed Advisors LLC 14.8M 15.6% Nov 12, 2024
Ra Capital Management, L.P. 8.9M
% of shares outstanding 9.6% Filing date Jan 29, 2024
Ra Capital Management, L.P. 8.9M 9.6% Jan 29, 2024
Blackrock, Inc. 6.4M
% of shares outstanding 6.8% Filing date Nov 8, 2024
Blackrock, Inc. 6.4M 6.8% Nov 8, 2024
Baker Bros. Advisors LP 5.8M
% of shares outstanding 6.2% Filing date Nov 14, 2024
Baker Bros. Advisors LP 5.8M 6.2% Nov 14, 2024
Novo Holdings A 5.5M
% of shares outstanding 5.9% Filing date Sep 23, 2024
Novo Holdings A 5.5M 5.9% Sep 23, 2024
Janus Henderson Group PLC 5.9M
% of shares outstanding 5.5% Filing date May 15, 2026
Janus Henderson Group PLC 5.9M 5.5% May 15, 2026
Citadel Advisors LLC 2.7M
% of shares outstanding 4.2% Filing date Feb 14, 2023
Citadel Advisors LLC 2.7M 4.2% Feb 14, 2023
BlackRock Inc. 3.5M
% of shares outstanding 4.1% Filing date Feb 7, 2024
BlackRock Inc. 3.5M 4.1% Feb 7, 2024
8 of 14

Edgewise Therapeutics, Inc. (EWTX) ownership FAQ

Who owns EWTX?

191 reporting institutions disclosed EWTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.